AUDITORY FUNCTION IN PEDIATRIC OSTEO-SARCOMA PATIENTS TREATED WITH MULTIPLE DOSES OF CIS-DIAMMINEDICHLOROPLATINUM(II)

被引：0
作者：
RUIZ, L [1 ]
GILDEN, J [1 ]
JAFFE, N [1 ]
ROBERTSON, R [1 ]
WANG, YM [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DIV HEAD & NECK SURG,HOUSTON,TX 77030
来源：
CANCER RESEARCH | 1989年 / 49卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：742 / 744
页数：3
相关论文
共 50 条
[41]   miR-34a is downregulated in cis-diamminedichloroplatinum treated sinonasal squamous cell carcinoma patients with poor prognosis [J].
Ogawa, Takenori ;
Saiki, Yuriko ;
Shiga, Kiyoto ;
Chen, Na ;
Fukushige, Shinichi ;
Sunamura, Makoto ;
Nagase, Hiroki ;
Hashimoto, Sho ;
Matsuura, Kazuto ;
Saijo, Shigeru ;
Kobayashi, Toshimitsu ;
Horii, Akira .
CANCER SCIENCE, 2012, 103 (09) :1737-1743
[42]   PHASE-II STUDY OF HIGH-DOSE METHOTREXATE IN PATIENTS WITH UNRESECTABLE METASTATIC OSTEO-SARCOMA [J].
EDMONSON, JH ;
CREAGAN, ET ;
GILCHRIST, GS .
CANCER TREATMENT REPORTS, 1981, 65 (5-6) :538-539
[43]   MULTIPLE AND IRREVERSIBLE BINDING OF CIS-DIAMMINEDICHLOROPLATINUM(II) TO HUMAN SERUM-ALBUMIN AND ITS EFFECT ON WARFARIN-BINDING [J].
YOTSUYANAGI, T ;
OHTA, N ;
FUTO, T ;
ITO, S ;
CHEN, D ;
IKEDA, K .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1991, 39 (11) :3003-3006
[44]   MONITORING OF INTERACTION PRODUCTS OF CIS-DIAMMINEDICHLOROPLATINUM(II) AND CIS-DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM(II) WITH DNA IN CELLS FROM PLATINUM-TREATED CANCER-PATIENTS [J].
TERHEGGEN, PMAB ;
DIJKMAN, R ;
BEGG, AC ;
DUBBELMAN, R ;
FLOOT, BGJ ;
HART, AAM ;
DENENGELSE, L .
CANCER RESEARCH, 1988, 48 (19) :5597-5603
[45]   CIS-DIAMMINEDICHLOROPLATINUM (II) ADMINISTERED BY 24-HOUR INFUSION IN THE TREATMENT OF PATIENTS WITH ADVANCED UPPER AERODIGESTIVE CANCER [J].
CREAGAN, ET ;
OFALLON, JR ;
WOODS, JE ;
INGLE, JN ;
SCHUTT, AJ ;
NICHOLS, WC .
CANCER, 1983, 51 (11) :2020-2023
[46]   POLYCLONAL ANTIBODIES TO QUANTITATE CIS-DIAMMINEDICHLOROPLATINUM(II) - DNA ADDUCTS IN CANCER-PATIENTS AND ANIMAL-MODELS [J].
POIRIER, MC ;
REED, E ;
ZWELLING, LA ;
OZOLS, RF ;
LITTERST, CL ;
YUSPA, SH .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1985, 62 (OCT) :89-94
[47]   PHASE-II STUDY OF CIS-DIAMMINEDICHLOROPLATINUM IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER [J].
FUJITA, J ;
SAIJO, N ;
EGUCHI, K ;
SHIMIZU, E ;
SHINKAI, T ;
TOMINAGA, K ;
SASAKI, Y ;
FUTAMI, H ;
SAKURAI, M ;
HOSHI, A .
JAPANESE JOURNAL OF CANCER RESEARCH, 1985, 76 (05) :420-423
[48]   RENAL TOXICITY WITH CUMULATIVE DOSES OF CIS-DIAMMINEDICHLOROPLATINUM-II IN PEDIATRIC-PATIENTS WITH OSTEOSARCOMA - EFFECT ON CREATININE CLEARANCE AND METHOTREXATE EXCRETION [J].
JAFFE, N ;
KEIFER, R ;
ROBERTSON, R ;
CANGIR, A ;
WANG, A .
CANCER, 1987, 59 (09) :1577-1581
[49]   CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND 24-HOUR INFUSION OF CIS-DIAMMINEDICHLOROPLATINUM(II) IN THE MANAGEMENT OF PATIENTS WITH ADVANCED HEAD AND NECK NEOPLASMS [J].
CREAGAN, ET ;
OFALLON, JR ;
SCHUTT, AJ ;
RUBIN, J ;
WOODS, JE .
HEAD & NECK SURGERY, 1984, 6 (03) :738-743
[50]   DIFFERENTIAL CYTO-TOXICITY AND DNA CROSS-LINKING IN NORMAL AND TRANSFORMED HUMAN-FIBROBLASTS TREATED WITH CIS-DIAMMINEDICHLOROPLATINUM(II) [J].
ERICKSON, LC ;
ZWELLING, LA ;
DUCORE, JM ;
SHARKEY, NA ;
KOHN, KW .
CANCER RESEARCH, 1981, 41 (07) :2791-2794
12345